krioprecipitaattivalmisteet
Krioprecipitaattivalmisteet are plasma-derived products used in the treatment of bleeding disorders, particularly in cases of severe bleeding or when fresh frozen plasma is not available. These products are derived from human plasma and contain a high concentration of fibrinogen, which is essential for blood clotting. The primary component of krioprecipitaattivalmisteet is fibrinogen, but they may also contain other clotting factors such as factor VIII and factor XIII.
Krioprecipitaattivalmisteet are typically administered intravenously and are used to quickly restore clotting capacity in the blood.
The preparation and quality control of krioprecipitaattivalmisteet are regulated by national and international standards to ensure